Zinc alleviates pain through high-affinity binding to the NMDA receptor NR2A subunit

Nature Neuroscience

Volumn 14, Issue 8, 2011, Pages 1017-1022

  Nozaki, Chihiro ^a,b,c,d   Vergnano, Angela Maria ^b,c,e   Filliol, Dominique ^a,b,c,d   Ouagazzal, Abdel Mouttalib ^a,b,c,d   Le Goff, Anne ^b,c,e   Carvalho, Stéphanie ^b,c,e   Reiss, David ^a,b,c,d   Gaveriaux Ruff, Claire ^b,c,e   Neyton, Jacques ^b,c,e   Paoletti, Pierre ^b,c,e   Kieffer, Brigitte L ^a,b,c,d  

^a INSTITUT DE GÉNÉTIQUE ET DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

^b CNRS   (France)

^c INSERM   (France)

^d UNIVERSITÉ DE STRASBOURG   (France)

^e ECOLE NORMALE SUPÉRIEURE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CAPSAICIN; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2A; ZINC CHLORIDE;

ALLODYNIA; ANALGESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHRONIC PAIN; CONTROLLED STUDY; DIET SUPPLEMENTATION; DRUG RECEPTOR BINDING; FEMALE; GENE TARGETING; HEAT; HIPPOCAMPUS; HYPERSENSITIVITY; IN VIVO STUDY; MALE; MOUSE; NEUROMODULATION; NEUROPATHIC PAIN; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; SPINAL CORD;

EID: 79960837047     PISSN: 10976256     EISSN: 15461726     Source Type: Journal    
DOI: 10.1038/nn.2844     Document Type: Article

References (49)

1. Hambidge, K.M. & Krebs, N.F. Zinc deficiency: a special challenge. J. Nutr. 137, 1101-1105 (2007). (Pubitemid 46596920)
2. Frederickson, C.J., Suh, S.W., Silva, D. & Thompson, R.B. Importance of zinc in the central nervous system: the zinc-containing neuron. J. Nutr. 130, 1471S-1483S (2000). (Pubitemid 30244148)
3. Vogt, K., Mellor, J., Tong, G. & Nicoll, R. The actions of synaptically released zinc at hippocampal mossy fiber synapses. Neuron 26, 187-196 (2000).
4. Ma, J.Y. & Zhao, Z.Q. The effects of Zn2+ on long-term potentiation of C fiber-evoked potentials in the rat spinal dorsal horn. Brain Res. Bull. 56, 575-579 (2001).
5. Ueno, S. et al. Mossy fiber Zn2+ spillover modulates heterosynaptic N-methyl-D-aspartate receptor activity in hippocampal CA3 circuits. J. Cell Biol. 158, 215-220 (2002).
6. Kodirov, S.A. et al. Synaptically released zinc gates long-term potentiation in fear conditioning pathways. Proc. Natl. Acad. Sci. USA 103, 15218-15223 (2006). (Pubitemid 44583191)
7. Hirzel, K. et al. Hyperekplexia phenotype of glycine receptor alpha1 subunit mutant mice identifies Zn(2+) as an essential endogenous modulator of glycinergic neurotransmission. Neuron 52, 679-690 (2006). (Pubitemid 44750561)
8. Sensi, S.L., Paoletti, P., Bush, A.I. & Sekler, I. Zinc in the physiology and pathology of the CNS. Nat. Rev. Neurosci. 10, 780-791 (2009).
9. Velázquez, R.A., Cai, Y., Shi, Q. & Larson, A.A. The distribution of zinc selenite and expression of metallothionein-III mRNA in the spinal cord and dorsal root ganglia of the rat suggest a role for zinc in sensory transmission. J. Neurosci. 19, 2288-2300 (1999). (Pubitemid 29133404)
10. Jo, S.M., Danscher, G., Schroder, H.D. & Suh, S.W. Depletion of vesicular zinc in dorsal horn of spinal cord causes increased neuropathic pain in mice. Biometals 21, 151-158 (2008). (Pubitemid 351421983)
11. Smart, T.G., Hosie, A.M. & Miller, P.S. Zn2+ ions: modulators of excitatory and inhibitory synaptic activity. Neuroscientist 10, 432-442 (2004). (Pubitemid 39244580)
12. Frederickson, C.J., Koh, J.Y. & Bush, A.I. The neurobiology of zinc in health and disease. Nat. Rev. Neurosci. 6, 449-462 (2005). (Pubitemid 40774861)
13. Paoletti, P., Vergnano, A.M., Barbour, B. & Casado, M. Zinc at glutamatergic synapses. Neuroscience 158, 126-136 (2009).
14. Traynelis, S.F. et al. Glutamate receptor ion channels: structure, regulation, and function. Pharmacol. Rev. 62, 405-496 (2010).
15. Woolf, C.J. & Salter, M.W. Neuronal plasticity: increasing the gain in pain. Science 288, 1765-1769 (2000).
16. Latremoliere, A. & Woolf, C.J. Central sensitization: a generator of pain hypersensitivity by central neural plasticity. J. Pain 10, 895-926 (2009).
17. Paoletti, P., Ascher, P. & Neyton, J. High-affinity zinc inhibition of NMDA NR1-NR2A receptors. J. Neurosci. 17, 5711-5725 (1997). (Pubitemid 27310487)
18. Paoletti, P. et al. Molecular organization of a zinc binding n-terminal modulatory domain in a NMDA receptor subunit. Neuron 28, 911-925 (2000). (Pubitemid 32038081)
19. Fayyazuddin, A., Villarroel, A., Le Goff, A., Lerma, J. & Neyton, J. Four residues of the extracellular N-terminal domain of the NR2A subunit control high-affinity Zn2+ binding to NMDA receptors. Neuron 25, 683-694 (2000).
20. Low, C.M., Zheng, F., Lyuboslavsky, P. & Traynelis, S.F. Molecular determinants of coordinated proton and zinc inhibition of N-methyl-D-aspartate NR1/NR2A receptors. Proc. Natl. Acad. Sci. USA 97, 11062-11067 (2000).
21. Gielen, M., Siegler Retchless, B., Mony, L., Johnson, J.W. & Paoletti, P. Mechanism of differential control of NMDA receptor activity by NR2 subunits. Nature 459, 703-707 (2009).
22. Scherrer, G. et al. Knockin mice expressing fluorescent delta-opioid receptors uncover G protein-coupled receptor dynamics in vivo. Proc. Natl. Acad. Sci. USA 103, 9691-9696 (2006). (Pubitemid 43955886)
23. Cole, T.B., Wenzel, H.J., Kafer, K.E., Schwartzkroin, P.A. & Palmiter, R.D. Elimination of zinc from synaptic vesicles in the intact mouse brain by disruption of the ZnT3 gene. Proc. Natl. Acad. Sci. USA 96, 1716-1721 (1999). (Pubitemid 29098517)
24. Basbaum, A.I., Bautista, D.M., Scherrer, G. & Julius, D. Cellular and molecular mechanisms of pain. Cell 139, 267-284 (2009).
25. Yeomans, D.C., Pirec, V. & Proudfit, H.K. Nociceptive responses to high and low rates of noxious cutaneous heating are mediated by different nociceptors in the rat: behavioral evidence. Pain 68, 133-140 (1996). (Pubitemid 126407765)
26. Le Bars, D., Gozariu, M. & Cadden, S.W. Animal models of nociception. Pharmacol. Rev. 53, 597-652 (2001). (Pubitemid 33136239)
27. Drdla, R. & Sandkuhler, J. Long-term potentiation at C-fibre synapses by low-level presynaptic activity in vivo. Mol. Pain 4, 18 (2008).
28. Matsumoto, M., Kondo, S., Usdin, T.B. & Ueda, H. Parathyroid hormone 2 receptor is a functional marker of nociceptive myelinated fibers responsible for neuropathic pain. J. Neurochem. 112, 521-530 (2010).
29. Svensson, C.I., Hua, X.Y., Protter, A.A., Powell, H.C. & Yaksh, T.L. Spinal p38 MAP kinase is necessary for NMDA-induced spinal PGE(2) release and thermal hyperalgesia. Neuroreport 14, 1153-1157 (2003). (Pubitemid 36930264)
30. Yaksh, T.L., Hua, X.Y., Kalcheva, I., Nozaki-Taguchi, N. & Marsala, M. The spinal biology in humans and animals of pain states generated by persistent small afferent input. Proc. Natl. Acad. Sci. USA 96, 7680-7686 (1999). (Pubitemid 29328340)
31. Vardeh, D. et al. COX2 in CNS neural cells mediates mechanical inflammatory pain hypersensitivity in mice. J. Clin. Invest. 119, 287-294 (2009).
32. Hu, H., Bandell, M., Petrus, M.J., Zhu, M.X. & Patapoutian, A. Zinc activates damage-sensing TRPA1 ion channels. Nat. Chem. Biol. 5, 183-190 (2009).
33. Larson, A.A. & Kitto, K.F. Manipulations of zinc in the spinal cord, by intrathecal injection of zinc chloride, disodium-calcium-EDTA, or dipicolinic acid, alter nociceptive activity in mice. J. Pharmacol. Exp. Ther. 282, 1319-1325 (1997). (Pubitemid 27408310)
34. Safieh-Garabedian, B. et al. Zinc reduces the hyperalgesia and upregulation of NGF and IL-1 beta produced by peripheral inflammation in the rat. Neuropharmacology 35, 599-603 (1996). (Pubitemid 26306776)
35. Liu, T., Walker, J.S. & Tracey, D.J. Zinc alleviates thermal hyperalgesia due to partial nerve injury. Neuroreport 10, 1619-1623 (1999). (Pubitemid 29354358)
36. Sendur, O.F., Tastaban, E., Turan, Y. & Ulman, C. The relationship between serum trace element levels and clinical parameters in patients with fibromyalgia. Rheumatol. Int. 28, 1117-1121 (2008).
37. Head, K.A. Peripheral neuropathy: pathogenic mechanisms and alternative therapies. Altern. Med. Rev. 11, 294-329 (2006). (Pubitemid 46037130)
38. Yoshida, H., Tsuji, K., Sakata, T., Nakagawa, A. & Morita, S. Clinical study of tongue pain: Serum zinc, vitamin B12, folic acid, and copper concentrations, and systemic disease. Br. J. Oral Maxillofac. Surg. 48, 469-472 (2010).
39. Al-Hallaq, R.A., Conrads, T.P., Veenstra, T.D. & Wenthold, R.J. NMDA di-heteromeric receptor populations and associated proteins in rat hippocampus. J. Neurosci. 27, 8334-8343 (2007). (Pubitemid 47219608)
40. Rauner, C. & Kohr, G. Triheteromeric NR1/NR2A/NR2B receptors constitute the major N-methyl-D-aspartate (NMDA) receptor population in adult hippocampal synapses. J. Biol. Chem. 286, 7558-7566 (2010).
41. Hatton, C.J. & Paoletti, P. Modulation of triheteromeric NMDA receptors by N-terminal domain ligands. Neuron 46, 261-274 (2005). (Pubitemid 40545781)
42. Mony, L., Kew, J.N., Gunthorpe, M.J. & Paoletti, P. Allosteric modulators of NR2B-containing NMDA receptors: molecular mechanisms and therapeutic potential. Br. J. Pharmacol. 157, 1301-1317 (2009).
43. Danscher, G. et al. Inhibitory zinc-enriched terminals in mouse spinal cord. Neuroscience 105, 941-947 (2001). (Pubitemid 32786807)
44. Sandkühler, J. Understanding LTP in pain pathways. Mol. Pain 3, 9 (2007).
45. Miledi, R., Eusebi, F., Martinez-Torres, A., Palma, E. & Trettel, F. Expression of functional neurotransmitter receptors in Xenopus oocytes after injection of human brain membranes. Proc. Natl. Acad. Sci. USA 99, 13238-13242 (2002).
46. Boyce, S. et al. Selective NMDA NR2B antagonists induce antinociception without motor dysfunction: correlation with restricted localisation of NR2B subunit in dorsal horn. Neuropharmacology 38, 611-623 (1999). (Pubitemid 29150316)
47. Ma, Q.P. & Hargreaves, R.J. Localization of N-methyl-D-aspartate NR2B subunits on primary sensory neurons that give rise to small-caliber sciatic nerve fibers in rats. Neuroscience 101, 699-707 (2000).
48. Gaveriaux-Ruff, C. et al. Genetic ablation of delta opioid receptors in nociceptive sensory neurons increases chronic pain and abolishes opioid analgesia. Pain 152, 1238-1248 (2011).
49. Sakurada, T., Katsumata, K., Tan-No, K., Sakurada, S. & Kisara, K. The capsaicin test in mice for evaluating tachykinin antagonists in the spinal cord. Neuropharmacology 31, 1279-1285 (1992). (Pubitemid 23002112)